International Agency For Research On Cancer
Clinical trials sponsored by International Agency For Research On Cancer, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- HPV Vaccine's Real-World impact under the microscope in sikkim Results expected Oct 2026 (estimated)
- Leg artery check may spot hidden lung cancer risk Results expected Jan 2027 (estimated)
-
AI-Powered urine test could revolutionize cervical cancer screening in Low-Income countries
Diagnosis Recruiting nowThis study is testing a new, affordable AI system to screen for cervical cancer in low- and middle-income countries. The AI analyzes urine samples and cervical images to detect high-risk HPV and precancerous changes. About 3,200 unscreened women aged 25-49 in Zimbabwe will take p…
Sponsor: International Agency for Research on Cancer • Aim: Diagnosis
Last updated Jun 27, 2026 13:00 UTC
-
Handheld ultrasound could cut unnecessary breast biopsies
Diagnosis Recruiting nowThis study in Indonesia will test whether a portable ultrasound device can help doctors quickly decide if a breast lump found during a physical exam is likely benign or possibly cancerous. 600 women with breast lumps will get an ultrasound at a primary care clinic. The goal is to…
Sponsor: International Agency for Research on Cancer • Aim: Diagnosis
Last updated Jun 27, 2026 09:04 UTC
-
HPV Vaccine's Real-World impact under the microscope in sikkim
Prevention Recruiting nowThis study checks how well the HPV vaccine prevents cervical HPV infection in women in Sikkim, India, about 7 years after the vaccine was introduced. Researchers will collect cervical samples from 5,500 married women aged 18-22 and compare infection rates to those before vaccinat…
Sponsor: International Agency for Research on Cancer • Aim: Prevention
Last updated Jun 27, 2026 12:03 UTC
-
AI to the rescue: boosting cervical cancer screening in underserved french regions
Knowledge-focused Recruiting nowThis study tests whether artificial intelligence can help more women in Occitanie, France, complete cervical cancer screening. About 3,000 women aged 30-65 who haven't been screened recently will be invited to use a self-sampling kit. The goal is to see if AI-assisted decision-ma…
Sponsor: International Agency for Research on Cancer • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC